AP
ANGO icon

AHL Partners’s AngioDynamics ANGO Stock Holding History

AHL Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-31,493
Closed -$538K – 1248
2017
Q3 		$538K Sell
31,493
-23,381
-43% -$393K 0.01% 1032
2017
Q2 		$890K Buy
54,874
+5,613
+11% +$88.7K 0.02% 811
2017
Q1 		$855K Buy
+49,261
New +$824K 0.02% 828
2016
Q4 		– Sell
-21,797
Closed -$382K – 1042
2016
Q3 		$382K Buy
21,797
+4,218
+24% +$68.4K 0.01% 907
2016
Q2 		$253K Buy
+17,579
New +$220K 0.01% 735

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $18.1B AUM 18.25% 1-Year Est. Return

AHL Partners's ANGO Position: Q4 2017 in Review

AHL Partners sold out of AngioDynamics (ANGO) in Q4 2017, closing a stake of 31,493 shares — an estimated $538K sold.

AHL Partners first reported a position in ANGO in Q2 2016 and held it in 5 quarters. The position peaked at $890K in Q2 2017. 169 funds tracked by Wall St. Rank hold ANGO as of Q4 2017.

  • AHL Partners reported no remaining AngioDynamics position as of Q4 2017 after selling out during the quarter.
  • AHL Partners sold 31,493 AngioDynamics shares in Q4 2017, an estimated $538K.
  • AHL Partners first reported a position in AngioDynamics in Q2 2016 and held it in 5 quarters.
  • AHL Partners's AngioDynamics position peaked at $890K in Q2 2017.
  • 169 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.